In vivo bioluminescence imaging of magnetically targeted bone marrow-derived mesenchymal stem cells in skeletal muscle injury model

Journal of Orthopaedic Research

Volumn 31, Issue 5, 2013, Pages 754-759

  Nakabayashi, Akihiro ^a   Kamei, Naosuke ^a,b   Sunagawa, Toru ^a   Suzuki, Osami ^a   Ohkawa, Shingo ^a   Kodama, Akira ^a   Kamei, Goki ^a   Ochi, Mitsuo ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

in vivo bioluminescence imaging; magnetic targeting system; mesenchymal stem cells; muscle regeneration; skeletal muscle injury

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLUMINESCENCE; BONE MARROW; IN VIVO STUDY; MAGNETISM; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MUSCLE INJURY; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; SKELETAL MUSCLE INJURY; TIBIA ANTERIOR MUSCLE;

ANIMALS; ATHLETIC INJURIES; CELL SEPARATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; LUCIFERASES; LUMINESCENT MEASUREMENTS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MUSCLE, SKELETAL; RATS; RATS, INBRED LEW; RATS, TRANSGENIC; REGENERATION;

EID: 84875215296     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22282     Document Type: Article

References (21)

1. Herring SA., 1990. Rehabilitation of muscle injuries. Med Sci Sports Exerc 22: 453-456.
2. Bernasconi P, Di Blasi C, Mora M, et al. 1999. Transforming growth factor-beta1 and fibrosis in congenital muscular dystrophies. Neuromuscul Disord 9: 28-33.
3. Chan YS, Li Y, Foster W, et al. 2005. The use of suramin, an antifibrotic agent, to improve muscle recovery after strain injury. Am J Sports Med 33: 43-51.
4. Matsuo T, Sugita T, Kubo T, et al. 2003. Injectable magnetic liposomes as a novel carrier of recombinant human BMP-2 for bone formation in a rat bone-defect model. J Biomed Mater Res A 66: 747-754.
5. Kobayashi T, Ochi M, Yanada S, et al. 2008. A novel cell delivery system using magnetically labeled mesenchymal stem cells and an external magnetic device for clinical cartilage repair. Arthroscopy 24: 69-76.
6. Nishida K, Tanaka N, Nakanishi K, et al. 2006. Magnetic targeting of bone marrow stromal cells into spinal cord: through cerebrospinal fluid. Neuroreport 17: 1269-1272.
7. Oshima S, Ishikawa M, Mochizuki Y, et al. 2010. Enhancement of bone formation in an experimental bony defect using ferumoxide-labelled mesenchymal stromal cells and a magnetic targeting system. J Bone Joint Surg Br 92: 1606-1613.
8. Arbab AS, Yocum GT, Rad AM, et al. 2005. Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells. NMR Biomed 18: 553-559.
9. Huang DM, Hsiao JK, Chen YC, et al. 2009. The promotion of human mesenchymal stem cell proliferation by superparamagnetic iron oxide nanoparticles. Biomaterials 30: 3645-3651.
10. Mailander V, Lorenz MR, Holzapfel V, et al. 2008. Carboxylated superparamagnetic iron oxide particles label cells intracellularly without transfection agents. Mol Imaging Biol 10: 138-146.
11. Hsiao JK, Tai MF, Chu HH, et al. 2007. Magnetic nanoparticle labeling of mesenchymal stem cells without transfection agent: cellular behavior and capability of detection with clinical 1.5 T magnetic resonance at the single cell level. Magn Reson Med 58: 717-724.
12. Natsu K, Ochi M, Mochizuki Y, et al. 2004. Allogeneic bone marrow-derived mesenchymal stromal cells promote the regeneration of injured skeletal muscle without differentiation into myofibers. Tissue Eng 10: 1093-1112.
13. Shi M, Ishikawa M, Kamei N, et al. 2009. Acceleration of skeletal muscle regeneration in a rat skeletal muscle injury model by local injection of human peripheral blood-derived CD133-positive cells. Stem Cells 27: 949-960.
14. Kobayashi T, Ochi M, Yanada S, et al. 2009. Augmentation of degenerated human cartilage in vitro using magnetically labeled mesenchymal stem cells and an external magnetic device. Arthroscopy 25: 1435-1441.
15. Cheng K, Li TS, Malliaras K, et al. 2010. Magnetic targeting enhances engraftment and functional benefit of iron-labeled cardiosphere-derived cells in myocardial infarction. Circ Res 106: 1570-1581.
16. Okada S, Ishii K, Yamane J, et al. 2005. In vivo imaging of engrafted neural stem cells: its application in evaluating the optimal timing of transplantation for spinal cord injury. FASEB J 19: 1839-1841.
17. de Boer J, van Blitterswijk C, Lowik C., 2006. Bioluminescent imaging: emerging technology for non-invasive imaging of bone tissue engineering. Biomaterials 27: 1851-1858.
18. Kidd S, Spaeth E, Dembinski JL, et al. 2009. Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging. Stem Cells 27: 2614-2623.
19. Pribaz JR, Bernthal NM, Billi F, et al. 2011. Mouse model of chronic post-arthroplasty infection: noninvasive in vivo bioluminescence imaging to monitor bacterial burden for long-term study. J Orthop Res 30: 335-340.
20. Hawke TJ, Garry DJ., 2001. Myogenic satellite cells: physiology to molecular biology. J Appl Physiol 91: 534-551.
21. Winkler T, von Roth P, Matziolis G, et al. 2009. Dose-response relationship of mesenchymal stem cell transplantation and functional regeneration after severe skeletal muscle injury in rats. Tissue Eng Part A 15: 487-492.